Cambridge Investment Research Advisors’s Calamos S&P 500 Structured Alt Protection ETF - May CPSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Buy
50,831
+3,916
+8% +$114K ﹤0.01% 1931
2026
Q1
$1.35M Buy
+46,915
New +$1.35M ﹤0.01% 1914
2025
Q1
Sell
-79,287
Closed -$2.12M 3658
2024
Q4
$2.12M Sell
79,287
-10,131
-11% -$269K 0.01% 1318
2024
Q3
$2.36M Sell
89,418
-311,733
-78% -$8.11M 0.01% 1223
2024
Q2
$10.3M Buy
+401,151
New +$10.2M 0.04% 450

Other funds holding CPSM

Cambridge Investment Research Advisors's CPSM Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Calamos S&P 500 Structured Alt Protection ETF - May (CPSM) stake by 8.3% in Q2 2026, buying an estimated $114K and bringing the position to 50,831 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #1931.

Cambridge Investment Research Advisors first reported a position in CPSM in Q2 2024 and has held it in 5 quarters since. The position peaked at $10.3M in Q2 2024. 30 funds tracked by Wall St. Rank hold CPSM as of Q2 2026.

  • Cambridge Investment Research Advisors held 50,831 shares of Calamos S&P 500 Structured Alt Protection ETF - May worth $1.49M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 3,916 Calamos S&P 500 Structured Alt Protection ETF - May shares in Q2 2026, an estimated $114K.
  • Calamos S&P 500 Structured Alt Protection ETF - May made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1931 holding.
  • Cambridge Investment Research Advisors first reported a position in Calamos S&P 500 Structured Alt Protection ETF - May in Q2 2024 and has held it in 5 quarters since.
  • Cambridge Investment Research Advisors's Calamos S&P 500 Structured Alt Protection ETF - May position peaked at $10.3M in Q2 2024.
  • 30 funds tracked by Wall St. Rank held Calamos S&P 500 Structured Alt Protection ETF - May as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.